fig1
From: Aging and rejuvenation of engineered cardiovascular tissues: from research to clinical application
Figure 1. Aging in engineered cardiovascular tissues. Dox: Doxorubicin; HGPS: hutchinson-gilford progeria syndrome; hCB-EPC: human cord blood-derived endothelial progenitor cells; iPSC: induced pluripotent stem cell; iCM: iPSC-derived cardiomyocyte; iSMC: iPSC-derived smooth muscle cells; NRCM: neonatal rat cardiomyocyte; ROS: reactive oxygen species; TEBV: tissue-engineered blood vessels.